Invitek Molecular

Executive Summary

Invitek Molecular is a private German molecular diagnostics company founded in 1998, headquartered in Berlin. It offers a comprehensive portfolio spanning the entire molecular workflow, including sample collection, nucleic acid extraction, detection kits, and custom DNA synthesis. The company serves diverse markets such as food safety testing, genomics, life sciences research, and animal health. With over 25 years of operational history, Invitek has built a reputation for reliable products that cover from sample to result. However, as a private entity, the company lacks public financial disclosures, making investment assessment challenging. Its strengths lie in its broad product range and custom synthesis capabilities, which provide flexibility for customers. Growth opportunities exist in expanding its footprint in emerging markets and deepening penetration in the animal health and food safety sectors. The company's ability to innovate in nucleic acid extraction and detection technologies remains a key competitive advantage. Overall, Invitek is a stable, niche player in the diagnostics space, but its private status limits visibility into near-term performance.

Upcoming Catalysts (preview)

• Q3 2026Launch of next-generation NGS library preparation kit70% success
• 2026Strategic partnership for veterinary diagnostics in Asia60% success
• Q1 2027Regulatory approval for automated extraction system in China50% success